Market: NASD |
Currency: USD
Address: 1000 Skokie Boulevard
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops MNPR-101-Zr, a clinical stage urokinase plasminogen activator receptor-targeted radiodiagnostic imaging agent; and MNPR-101-RIT, a late preclinical stage radiotherapeutic for advanced cancers. It also develops Camsirubicin, a Phase 1b clinical stage novel analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; and MNPR-202, an analog of Camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Monopar Therapeutics Inc. is a subsidiary of Tacticgem LLC.
Show more
📈 Monopar Therapeutics Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$82.33
-
Upside/Downside from Analyst Target:
86.26%
-
Broker Call:
12
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2024 |
- |
$0.200000 |
- |
2024-08-13 |
- |
Stock split |
|
Total Amount for 2024: $0.200000 |
📅 Earnings & EPS History for Monopar Therapeutics Inc.
| Date | Reported EPS |
|---|
| 2025-08-12 | -0.35 |
| 2025-05-13 | -0.38 |
| 2025-03-31 | -2.75 |
| 2024-11-08 | -1.85 |
| 2024-08-09 | -0.5 |
| 2024-05-09 | -0.5 |
| 2024-03-28 | -0.6 |
| 2023-11-09 | -0.7 |
| 2023-08-10 | -0.8 |
| 2023-05-11 | -0.95 |
| 2023-03-23 | -1.15 |
| 2022-11-10 | -0.95 |
| 2022-08-11 | -1.1 |
| 2022-05-12 | -0.95 |
| 2022-03-24 | -1.05 |
| 2021-11-12 | -1 |
| 2021-08-12 | -0.85 |
| 2021-05-13 | -0.8 |
| 2021-03-25 | -0.95 |
| 2020-11-12 | -0.75 |
| 2020-08-06 | -0.7 |
| 2020-03-27 | -0.57 |
📰 Related News & Research
No related articles found for "monopar therapeutics".
